ATE382683T1 - Monoklonales antikörper gegen das hcv kernantigen - Google Patents
Monoklonales antikörper gegen das hcv kernantigenInfo
- Publication number
- ATE382683T1 ATE382683T1 AT02257622T AT02257622T ATE382683T1 AT E382683 T1 ATE382683 T1 AT E382683T1 AT 02257622 T AT02257622 T AT 02257622T AT 02257622 T AT02257622 T AT 02257622T AT E382683 T1 ATE382683 T1 AT E382683T1
- Authority
- AT
- Austria
- Prior art keywords
- core antigen
- hcv core
- monoclonal antibody
- antibody against
- antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—RNA viruses
- C07K16/116—Togaviridae (F); Matonaviridae (F); Flaviviridae (F)
- C07K16/118—Hepatitis C virus; GB virus C [GBV-C]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33745301P | 2001-11-05 | 2001-11-05 | |
| US10/268,561 US7049060B2 (en) | 2001-11-05 | 2002-10-10 | HCV anti-core monoclonal antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE382683T1 true ATE382683T1 (de) | 2008-01-15 |
Family
ID=26953173
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07075928T ATE459706T1 (de) | 2001-11-05 | 2002-11-04 | Monoklonales antikörper gegen das hcv kernantigen |
| AT02257622T ATE382683T1 (de) | 2001-11-05 | 2002-11-04 | Monoklonales antikörper gegen das hcv kernantigen |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07075928T ATE459706T1 (de) | 2001-11-05 | 2002-11-04 | Monoklonales antikörper gegen das hcv kernantigen |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7049060B2 (de) |
| EP (3) | EP2186884A3 (de) |
| JP (1) | JP2004035534A (de) |
| AT (2) | ATE459706T1 (de) |
| CA (1) | CA2406240C (de) |
| DE (2) | DE60224346T2 (de) |
| DK (2) | DK1308507T3 (de) |
| ES (2) | ES2295292T3 (de) |
| PT (2) | PT1308507E (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8658773B2 (en) | 2011-05-02 | 2014-02-25 | Immunomedics, Inc. | Ultrafiltration concentration of allotype selected antibodies for small-volume administration |
| US7902338B2 (en) | 2003-07-31 | 2011-03-08 | Immunomedics, Inc. | Anti-CD19 antibodies |
| JP2009018990A (ja) * | 2005-10-25 | 2009-01-29 | Univ Kurume | Ｃ型肝炎ウイルス由来ペプチド |
| US7858752B2 (en) | 2006-12-05 | 2010-12-28 | Abbott Laboratories | Recombinant antibodies against hepatitis C virus and methods of obtaining and using same |
| ES3000111T3 (en) | 2009-02-13 | 2025-02-27 | Immunomedics Inc | Intermediates for preparing conjugates with an intracellularly-cleavable linkage |
| US20160095939A1 (en) | 2014-10-07 | 2016-04-07 | Immunomedics, Inc. | Neoadjuvant use of antibody-drug conjugates |
| EP2478110B1 (de) | 2009-09-16 | 2016-01-06 | Immunomedics, Inc. | Klasse-i-anti-cea-antikörper und verwendungen davon |
| ES2978177T3 (es) | 2009-12-02 | 2024-09-06 | Immunomedics Inc | Combinación de radio inmunoterapia y conjugados anticuerpo-fármaco para mejorar la terapia contra el cáncer |
| WO2012006500A2 (en) * | 2010-07-08 | 2012-01-12 | Abbott Laboratories | Monoclonal antibodies against hepatitis c virus core protein |
| FR2984328B1 (fr) | 2011-12-20 | 2016-12-30 | Bio-Rad Innovations | Procede de detection d'une infection par le virus de l'hepatite c |
| CN104379169A (zh) | 2012-08-14 | 2015-02-25 | Ibc药品公司 | 用于治疗疾病的t-细胞重定向双特异性抗体 |
| CN107753954A (zh) | 2012-12-13 | 2018-03-06 | 免疫医疗公司 | 功效改进且毒性降低的抗体与sn‑38的免疫缀合物的剂量 |
| WO2017004144A1 (en) | 2015-07-01 | 2017-01-05 | Immunomedics, Inc. | Antibody-sn-38 immunoconjugates with a cl2a linker |
| WO2014143343A1 (en) * | 2013-03-14 | 2014-09-18 | Abbott Laboratories | Hcv core lipid binding domain monoclonal antibodies |
| MX362075B (es) | 2013-03-14 | 2019-01-07 | Abbott Lab | Ensayo de combinación de antígeno-anticuerpo del virus de la hepatitis c (vhc) y métodos y composiciones para usarlo. |
| JP2016512241A (ja) | 2013-03-14 | 2016-04-25 | アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ | 改良された抗体検出のためのｈｃｖｎｓ３組換え抗原およびこの突然変異体 |
| JP6447933B2 (ja) | 2014-02-21 | 2019-01-09 | アイビーシー ファーマスーティカルズ，インコーポレイテッド | Ｔｒｏｐ−２発現細胞に対する免疫応答を誘発することによる疾患治療 |
| CA2935748A1 (en) | 2014-02-25 | 2015-09-03 | Immunomedics, Inc. | Humanized rfb4 anti-cd22 antibody |
| EP3160504B1 (de) | 2014-06-24 | 2020-09-16 | Immunomedics, Inc. | Antihistontherapie für vaskuläre nekrose bei schwerer glomerulonephritis |
| AU2016252771B2 (en) | 2015-04-22 | 2021-12-16 | Immunomedics, Inc. | Isolation, detection, diagnosis and/or characterization of circulating Trop-2-positive cancer cells |
| JP6980980B2 (ja) | 2015-06-25 | 2021-12-15 | イミューノメディクス、インコーポレイテッドImmunomedics, Inc. | 抗ｈｌａ‐ｄｒまたは抗ｔｒｏｐ‐２抗体と微小管阻害剤、ｐａｒｐ阻害剤、ブルトンキナーゼ阻害剤またはホスホイノシチド３‐キナーゼ阻害剤との併用は癌の治療効果を有意に改善する |
| ES2796479T3 (es) | 2016-05-31 | 2020-11-27 | Hoffmann La Roche | Procedimiento de pretratamiento para la detección rápida del antígeno central del VHC |
| JP2019523863A (ja) | 2016-05-31 | 2019-08-29 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | ウイルス抗原の血清学的検出方法 |
| JP7068323B2 (ja) | 2017-02-02 | 2022-05-16 | エフ．ホフマン－ラ ロシュ アーゲー | 少なくとも２種のペグ化された分析物特異的結合剤を使用する免疫アッセイ |
| CN110996986B (zh) | 2017-07-27 | 2024-07-19 | 豪夫迈·罗氏有限公司 | Hcv抗原的多表位融合蛋白及其用途 |
| CN109738648B (zh) * | 2018-12-29 | 2021-09-17 | 山东莱博生物科技有限公司 | 稳定高效表达丙型肝炎病毒核心抗原抗体的工程细胞株及其应用 |
| WO2022239720A1 (ja) | 2021-05-10 | 2022-11-17 | 公益財団法人川崎市産業振興財団 | 抗原への結合親和性を低減させた抗体 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0185373B1 (ko) | 1989-03-17 | 1999-05-01 | 로버트 피. 블랙버언 | Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용 |
| DE4209215A1 (de) * | 1991-07-04 | 1993-01-07 | Boehringer Mannheim Gmbh | Hcv peptidantigene und verfahren zur bestimmung von hcv |
| ZA927837B (en) | 1991-10-15 | 1994-03-11 | Akzo Nv | Monoclonal antibodiesto hepatitis C virus |
| JP3217600B2 (ja) * | 1994-07-12 | 2001-10-09 | 株式会社先端生命科学研究所 | 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ |
| FR2775690B1 (fr) | 1998-03-09 | 2001-12-14 | Bio Merieux | Anticorps monoclonal et utilisations pour detecter des antigenes de la proteine core de vhc |
| US20030022155A1 (en) * | 1999-04-14 | 2003-01-30 | Agata Budkowska | Method for detecting hepatitis c virus with hybridomas |
| SI1354204T2 (sl) * | 2000-06-15 | 2010-09-30 | Novartis Vaccines & Diagnostic | Hcv antigen antitelo kombinacijska analiza |
| JP4353793B2 (ja) * | 2001-06-26 | 2009-10-28 | アボット・ラボラトリーズ | Ｈｃｖ抗原とｈｃｖ抗体との同時検出のための方法 |
-
2002
- 2002-10-10 US US10/268,561 patent/US7049060B2/en not_active Expired - Lifetime
- 2002-11-04 ES ES02257622T patent/ES2295292T3/es not_active Expired - Lifetime
- 2002-11-04 AT AT07075928T patent/ATE459706T1/de active
- 2002-11-04 DK DK02257622T patent/DK1308507T3/da active
- 2002-11-04 ES ES07075928T patent/ES2339709T3/es not_active Expired - Lifetime
- 2002-11-04 PT PT02257622T patent/PT1308507E/pt unknown
- 2002-11-04 DE DE60224346T patent/DE60224346T2/de not_active Expired - Lifetime
- 2002-11-04 DE DE60235588T patent/DE60235588D1/de not_active Expired - Lifetime
- 2002-11-04 AT AT02257622T patent/ATE382683T1/de active
- 2002-11-04 EP EP10002088A patent/EP2186884A3/de not_active Withdrawn
- 2002-11-04 EP EP07075928A patent/EP1881064B1/de not_active Expired - Lifetime
- 2002-11-04 PT PT07075928T patent/PT1881064E/pt unknown
- 2002-11-04 EP EP02257622A patent/EP1308507B1/de not_active Expired - Lifetime
- 2002-11-04 DK DK07075928.7T patent/DK1881064T3/da active
- 2002-11-05 JP JP2002321058A patent/JP2004035534A/ja active Pending
- 2002-11-05 CA CA2406240A patent/CA2406240C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1308507A3 (de) | 2003-10-22 |
| EP1308507A2 (de) | 2003-05-07 |
| DK1308507T3 (da) | 2008-05-19 |
| EP1881064A2 (de) | 2008-01-23 |
| EP1881064A3 (de) | 2008-04-09 |
| ES2295292T3 (es) | 2008-04-16 |
| ES2339709T3 (es) | 2010-05-24 |
| CA2406240A1 (en) | 2003-05-05 |
| DE60224346D1 (de) | 2008-02-14 |
| CA2406240C (en) | 2011-01-04 |
| EP2186884A3 (de) | 2010-09-08 |
| PT1308507E (pt) | 2008-03-31 |
| DK1881064T3 (da) | 2010-06-07 |
| EP1881064B1 (de) | 2010-03-03 |
| JP2004035534A (ja) | 2004-02-05 |
| PT1881064E (pt) | 2010-03-31 |
| EP1308507B1 (de) | 2008-01-02 |
| EP2186884A2 (de) | 2010-05-19 |
| DE60224346T2 (de) | 2008-12-24 |
| US7049060B2 (en) | 2006-05-23 |
| DE60235588D1 (de) | 2010-04-15 |
| US20030148333A1 (en) | 2003-08-07 |
| ATE459706T1 (de) | 2010-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE382683T1 (de) | Monoklonales antikörper gegen das hcv kernantigen | |
| DK1716181T3 (da) | CDR-reparerede antistoffer | |
| NO2017032I1 (no) | bezlotoksumab | |
| WO2003100033A3 (en) | ANTI-αvβ6 ANTIBODIES | |
| EP1607404A4 (de) | Monoklonaler antikörper und hybridom, das diesen produziert | |
| ATE554107T1 (de) | Als therapeutika geeignete monovalente antikörperfragmente | |
| DE60222658D1 (de) | Monoklonaler anti-cd-40-antikörper | |
| ATE248192T1 (de) | HUMANISIERTE ANTIKÖRPER DIE AN DAS GLEICHE ANTIGEN WIE ANTIKÖRPER NR-LU-13 BINDEN UND DEREN VERWENDUNG IN ßPRETARGETINGß VERFAHREN | |
| ATE520716T1 (de) | Humanisierter anti-cd4-antikörper mit immunsuppressiven eigenschaften | |
| GB2383331A (en) | Monoclonal antibody DS6 Tumor-associated antigen CA6 and methods of use thereof | |
| DK1478667T3 (da) | Monoklonalt anti-humant tenascin-antistof | |
| ATE517340T1 (de) | Sätze gegen kurze epitope gerichteter digitaler antikörper sowie diese verwendende verfahren | |
| DE60045870D1 (de) | Monoklonaler antikörper, hybridoma, immuntestverfahren und diagnosekit | |
| BR0015872A (pt) | Agentes antitrombóticos | |
| DK0840620T3 (da) | IL-8-antagonister til behandling af astma | |
| DK1263790T3 (da) | Monoklonale antistoffer for den humane LDL-receptor, deres produktionsmetode og anvendelse | |
| FI20020807A0 (fi) | Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita | |
| NO20080409L (no) | Fremgangsmater og preparater til malsoking av IFNAR2 | |
| FI20011055A0 (fi) | Heveiiniä sitovat monoklonaaliset vasta-aineet | |
| AR037216A1 (es) | Anticuerpos monoclonales antinucleares de hcv | |
| EP1483292A4 (de) | Mit bakteriellen collagen-bindenden proteinen kreuzreaktive monoklonale antikörper | |
| DE69227776D1 (de) | Monoklonale antikörper gegen mutmassliche hepatitis c-virus ns5-proteine und ihre anwendungsmethoden | |
| BR0204612A (pt) | Anticorpos monoclonais antinúcleo de hcv | |
| ATE535259T1 (de) | Immunogener, monoklonaler antikörper | |
| BR1100555B1 (pt) | anticorpos monoclonais humanizados. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1308507 Country of ref document: EP |